CMS announces new repayment terms for Accelerated and Advance Payment programs

Oct 09, 2020 - 01:45 PM
CMS logo

The Centers for Medicare & Medicaid Services yesterday announced new repayment terms for payments received under its Accelerated and Advance Payment programs, including a longer time period before repayment, lower recoupment rates during repayment, lower interest on remaining unpaid balance, and additional repayment flexibilities.

The announcement implements provisions of the Continuing Appropriations Act, 2021 and Other Extensions Act, which was enacted on Oct. 1, 2020.

The repayment terms are amended for all providers and suppliers who requested and received AAPs during the COVID-19 public health emergency. In addition to describing the new terms, CMS announced that the agency no longer will accept applications for AAPs as they relate to COVID-19. CMS also clarified that Provider Relief Funds can be used toward repayment of these Medicare loans.

Related News Articles

Headline
AHA, others urge CMS to ensure ACOs, MIPS-eligible clinicians are protected from increased skin substitute spending
A coalition of organizations, including the AHA, urged the Centers for Medicare & Medicaid Services to ensure accountable care organizations and Merit-…
Headline
AHA, others file suit to block unlawful 340B changes threatening patient care
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
CMS to launch payment model for expansion of technology-supported care access
The Centers for Medicare & Medicaid Services Innovation Center will launch a new, outcome-aligned payment model for providers offering technology-supported…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Chairperson's File
Chair File: Leadership Dialogue — The Importance of the 340B Program with Aimee Kuhlman of the AHA and Paulette Davidson of Monument Health
Public
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…